Boopathy Ramakrishnan

USPTO Granted Patents = 21 (Patent Applications = 18)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 21(Granted Patents)

Location History:

Braintree, MA (US) (2019 - 2024)
Waltham, MA (US) (2023 - 2024)

Company Filing History:

The General Hospital Corporation

patents

where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12415865 - Antibody molecules to C5AR1 and uses thereof (2025-09-16),

2. 12338291 - Humanized antibody molecules to CD138 and uses thereof (2025-06-24),

3. 12297249 - Interleukin-2 agents and uses thereof (2025-05-13),

4. 12264203 - Humanized complement 5a receptor 1 antibodies and methods of use thereof (2025-04-01),

5. 12227587 - Humanized complement 5A receptor 1 antibodies and methods of use thereof (2025-02-18),

6. 12187807 - Antibody molecules to C5AR1 and uses thereof (2025-01-07),

7. 12098178 - Methods of using interleukin-2 agents (2024-09-24),

8. 12091451 - Method of using antibody molecules to detect a proliferation-inducing ligand (APRIL) (2024-09-17),

9. 12084484 - Interleukin-2 agents and uses thereof (2024-09-10),

10. 11969476 - Antibody molecule-drug conjugates and uses thereof (2024-04-30),

11. 11945868 - Antibody molecules to CD138 and uses thereof (2024-04-02),

12. 11912781 - Humanized complement 5A receptor 1 antibodies and methods of use thereof (2024-02-27),

13. 11890319 - Antibody molecule-drug conjugates and uses thereof (2024-02-06),

14. 11858980 - Engineered polypeptides and uses thereof (2024-01-02),

15. 11773179 - Antibody molecules to C5aR1 and uses thereof (2023-10-03),

Title: Innovator Boopathy Ramakrishnan: Pioneering Advancements in Complement Research

Introduction

Boopathy Ramakrishnan, located in Braintree, MA, has established himself as a prominent inventor with a total of 18 patents to his name. His innovative contributions to the field of biomedical research focus primarily on the complexities of the complement system, which plays a crucial role in immune responses.

Latest Patents

Ramakrishnan's latest patents include groundbreaking work on humanized complement 5a receptor 1 antibodies and methods of use thereof. The patent discloses two different formats of humanized antibodies against human complement component 5a receptor 1. This work outlines a method for treating patients with dysfunctions in the C5a/C5aR1 axis pathway, specifically targeting conditions like ANCA-associated vasculitis. The administration of an effective amount of these antibodies or nucleic acids encoding the antibodies can significantly reduce symptoms related to C5a/C5aR1 dysfunction.

Career Highlights

Throughout his career, Ramakrishnan has collaborated with notable companies, including Visterra, Inc. and The General Hospital Corporation. These companies have provided him a platform to further his research and innovation in the medical field, solidifying his reputation as a leading inventor.

Collaborations

Working alongside talented individuals such as Zachary Shriver and Karthik Viswanathan, Ramakrishnan has fostered a collaborative spirit that enhances the potential for innovation. These partnerships have contributed to the success of his projects and patents.

Conclusion

Boopathy Ramakrishnan's impressive portfolio of patents and his collaborative efforts in research signify his commitment to advancing healthcare solutions through innovation. His work with complement 5a receptor antibodies represents a significant leap forward in treating complex immune-related disorders, showcasing the vital role inventors like him play in shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.